Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

Clinical trial NCT04786223 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT04786223
Sponsor: Val Lowe
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Lewy Body Dementia (LBD)Alzheimer Dementia (AD)

Start date: 2021-03-30
Primary completion: 2029-03-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.